Dermata Therapeutics Inc (DRMA) Financials

$1.20

$0.00 (0.00%)

As on 11-Sep-2026 16:00EDT

Market cap

$6 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	8.60	7.77	12.51	8.04	9.67	7.86
Operating Profit (EBIT)	-8.60	-7.77	-12.51	-8.04	-9.67	-7.86
Other Income	--	--	--	--	--	--
Profit before Tax	-8.37	-7.56	-12.29	-7.80	-9.61	-7.90
Provision for Tax	--	--	--	-0.01	-0.01	0.05
Profit after Tax (Net Income)	-8.37	-7.56	-12.29	-7.80	-9.61	-7.95
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-9.61	-10.46

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	3.49	6.22	1.56	6.36	6.02	10.11
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	1,164.78	757.59	--	--
Current Liabilities	1.83	1.64	1.97	1.62	0.92	1.52
Total Liabilities	7.15	7.86	3.53	7.98	6.94	11.62

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.16	--	-3,158.04	540.50	703.19	0.06
Current Assets	5.16	7.86	3.53	7.98	6.94	11.62
Total Assets	7.15	7.86	3.53	7.98	6.94	11.62
Total Debt*	--	--	--	--	--	--
Net Current Assets	3.32	6.22	1.56	6.36	6.02	10.11

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-7.76	-11.16	-6.41	-8.83	-5.69
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	12.12	6.89	7.61	4.28	15.96
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-4.39	-6.18	-79.02	-19.83	-124.82	-9.52
Cash EPS ($)	-4.31	-6.18	-79.02	-19.83	-124.82	-9.52
Adjusted Book Value ($)	0.87	5.09	10.04	16.17	78.21	12.10
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-6.34	-71.79	-16.30	-114.73	-6.82
Free Cash Flow per Share ($)	--	-6.34	-71.79	-16.30	-114.73	-6.82

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-194.20	-310.44	-125.96	-119.18	-151.76
ROE (%)	-172.35	-194.20	-310.44	-125.96	-119.18	-229.41
ROA (%)	-112.93	-132.63	-213.46	-104.47	-103.52	-129.98
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	-218.16	19.43	-23.13	-158.51
Net Profit Growth (%)	18.98	38.49	-57.63	18.89	-20.92	-145.57
EPS Growth (%)	90.63	0.92	-2.98	0.84	-12.12	-1.45
Book Value Growth (%)	-84.15	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.38	-0.02	-0.03	0.00	-0.18
Price / Book Value	1.68	0.46	0.13	0.04	0.01	0.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.58	0.60	257.28	-29.12	0.64	1.19
Close Price ($)	1.29	2.32	13.50	6.10	65.44	278.40
High Price ($)	8.00	23.70	57.90	86.40	392.00	1,112.00
Low Price ($)	1.10	1.58	2.32	5.50	25.94	0.02
Market Cap ($ Cr)	5.90	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	2.81	4.79	1.79	4.91	7.53	7.66
Quick Ratio	2.73	--	--	--	--	--
Interest Coverage	--	--	--	--	-152.18	-172.25

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.